Status:
RECRUITING
18F-FDG PET/CT Imaging for Breast Cancer
Lead Sponsor:
Vestre Viken Hospital Trust
Conditions:
Breast Cancer Female
Breast Cancer Recurrent
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Purpose To investigate the ability of 18F-FDG PET/CT imaging to detect metastases not detected by conventional imaging (CT and bone scintigraphy) in patients diagnosed with stage II/III and locoregion...
Eligibility Criteria
Inclusion Criteria:
- Patients with high risk primary or recurrent breast cancer
- Non pregnant women > 18 years
- Not receiving active treatment of other cancer types.
- Eastern Cooperative Oncology Group (ECOG) status 0-2.
Exclusion Criteria:
- Pregnant woman
- Males
- Age under 18
- Patients receiving active treatment for other cancers
- Poor general conditipon (ECOG 3 or higher)
Key Trial Info
Start Date :
February 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2032
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05730608
Start Date
February 16 2023
End Date
December 31 2032
Last Update
May 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Drammen Hospital - Vestre Viken HF
Drammen, Norway, N-3004